Longitudinal studies allow us to investigate the natural history of chronic diseases. For some diseases the evolution of the process is characterized by transitions between a series of health states. For example, in cancer, subjects may transition from a cancer-free state to early stage disease, and subsequently to late stage disease. Semi-Markov processes provide a flexible framework for modeling multi-state disease processes. However, limited estimation methods are available for the application of Semi-Markov processes to the study of multi-state disease. Existing estimation methods require the imposition of numerous assumptions on the process, which may not be biologically plausible for many diseases. The lack of estimation methods is particularly acute for data collected under panel observation. In this proposal we develop flexible and biologically appropriate methods for estimating Semi-Markov processes in longitudinal multi-state disease studies. We propose a class of time transformation functions that allows us to bridge Semi-Markov and Markov processes in order to harness the straightforward estimation methods available for Markov processes. We then propose to use mixture models, coupled with a set of biologically reasonable assumptions, to extend these methods to allow for estimation under panel observation. These methods will be applied to the estimation of breast cancer recurrence rates and rates of second primary breast cancers subsequent to an incident breast cancer. Using 13 years of longitudinal data from the Breast Cancer Surveillance Consortium, we will demonstrate improved performance of our novel methods for estimating transition rates among breast event states relative to Markov process models and proportional hazards survival models.

Public Health Relevance

Semi-Markov processes provide a flexible framework for modeling multi-state diseases characterized by transitions between a series of health states. However, limited estimation methods are available for the application of such processes. We will develop flexible methods for estimating Semi-Markov processes and will use our novel estimation methods to study rates of breast cancer recurrence and second primary breast cancers subsequent to an incident breast cancer using longitudinal data from the Breast Cancer Surveillance Consortium.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA160239-02
Application #
8326596
Study Section
Biostatistical Methods and Research Design Study Section (BMRD)
Program Officer
Dunn, Michelle C
Project Start
2011-09-01
Project End
2014-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
2
Fiscal Year
2012
Total Cost
$308,368
Indirect Cost
$102,529
Name
University of Washington
Department
Biostatistics & Other Math Sci
Type
Schools of Public Health
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Inoue, Lurdes Y T; Lin, Daniel W; Newcomb, Lisa F et al. (2018) Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts. Ann Intern Med 168:1-9
Hubbard, R A; Lange, J; Zhang, Y et al. (2016) Using semi-Markov processes to study timeliness and tests used in the diagnostic evaluation of suspected breast cancer. Stat Med 35:4980-4993
Lange, Jane M; Hubbard, Rebecca A; Inoue, Lurdes Y T et al. (2015) A joint model for multistate disease processes and random informative observation times, with applications to electronic medical records data. Biometrics 71:90-101
Inoue, Lurdes Y T; Trock, Bruce J; Partin, Alan W et al. (2014) Modeling grade progression in an active surveillance study. Stat Med 33:930-9
Chan, Kwun Chuen Gary (2013) Nuisance parameter elimination for proportional likelihood ratio models with nonignorable missingness and random truncation. Biometrika 100:
Chan, Kwun Chuen Gary (2013) Survival analysis without survival data: connecting length-biased and case-control data. Biometrika 100:
Lange, Jane M; Minin, Vladimir N (2013) Fitting and interpreting continuous-time latent Markov models for panel data. Stat Med 32:4581-95